Sonic Healthcare Limited (SKHCF)

Market Cap	7.73B -9.3%
Revenue (ttm)	6.32B +7.6%
Net Income	336.72M +0.5%
EPS	0.70 -0.5%
Shares Out	n/a
PE Ratio	22.95
Forward PE	17.95
Dividend	0.68 (4.25%)
Ex-Dividend Date	Sep 3, 2025

Volume	1,387
Average Volume	6,116
Open	16.10
Previous Close	16.10
Day's Range	16.10 - 16.10
52-Week Range	12.70 - 19.34
Beta	0.54
RSI	57.91
Earnings Date	Feb 12, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 45,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKHCF

Financial Performance

In fiscal year 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.

Financial numbers in AUD